Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...

The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers.

GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

Compared with DPP-4 inhibitors, elderly patients with type 2 diabetes had lower composite rates of heart attack, stroke, ...

GPs will be able to start prescribing the weight loss injection tirzepatide (Mounjaro) to a defined group of patients from ...